Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Multicentre Randomised Double-blind Comparative Study of Efficacy and Safety of Lanreotide 30 mg Versus Placebo for Treatment of Patients With Digestive Fistulae

NCT00729313 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT00729313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00729313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Multicentre Randomised Double-blind Comparative Study of Efficacy and Safety of Lanreotide 30 mg Versus Placebo for Treatment of Patients With Digestive Fistulae
Lead sponsor
Ipsen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2000
Completion date
April 30, 2005
Enrollment
111 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

digestive fistulae